Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Theravance Biopharma Inc shares valued at $36,000 were sold by Farnum Rhonda on Nov 11 ’24. At $9.00 per share, Farnum Rhonda sold 4,000 shares. The insider’s holdings dropped to 322,743 shares worth approximately $2.92 million following the completion of this transaction.
Also, Samaha Eli purchased 999,800 shares, netting a total of over 7,798,440 in proceeds. Following the buying of shares at $7.80 each, the insider now holds 9,511,150 shares.
Before that, Farnum Rhonda had sold 4,000 shares from its account. In a trade valued at $36,000, the SVP, COMM & MEDICAL AFFAIRS traded Theravance Biopharma Inc shares for $9.00 each. Upon closing the transaction, the insider’s holdings decreased to 4,000 shares, worth approximately $3.04 million.
As published in a research note from Leerink Partners on August 06, 2024, Theravance Biopharma Inc [TBPH] has been rated down from an Outperform to a Market perform and the price target has been revised to $10 from $15. Analysts at BTIG Research started covering the stock with ‘”a Buy”‘ outlook in a report released in mid April. As of January 08, 2024, Evercore ISI has decreased its “an Outperform” rating to a “an In-line” for TBPH. Earlier on May 23, 2022, SVB Leerink initiated its rating. Their recommendation was “an Outperform” for TBPH stock.
Analyzing TBPH Stock Performance
During the last five days, there has been a drop of approximately -3.83%. Over the course of the year, Theravance Biopharma Inc shares have dropped approximately -3.83%. Shares of the company reached a 52-week high of $9.56 on 01/03/25 and a 52-week low of $8.99 on 01/08/25. A 50-day SMA is recorded $9.38, while a 200-day SMA reached $8.93. Nevertheless, trading volume fell to 0.15 million shares from 0.16 million shares the previous day.
Support And Resistance Levels for Theravance Biopharma Inc (TBPH)
According to the 24-hour chart, there is a support level at 8.90, which, if violated, would cause prices to drop to 8.76. In the upper region, resistance lies at 9.29. The next price resistance is at 9.53. RSI (Relative Strength Index) is 37.07 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.34, which suggests the price will decrease in the coming days. Percent R is at 94.93%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
